Literature DB >> 7359370

The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis.

B H Lauterburg, Y Vaishnav, W G Stillwell, J R Mitchell.   

Abstract

We have validated a method to assess hepatic glutathione turnover in individual animals in vivo. This method would be applicable to man by collection of bile samples via nasoduodenal intubation. The rate of glutathione turnover was calculated from the time course of the specific activity of the glutathione-acetaminophen adduct in bile after the administration of a radiolabeled glutathione precursor and a small dose of acetaminophen. Identical results were obtained with radiolabeled glutathione or with radiolabeled cysteine, glutamic acid or glycine as the precursors. The small dose of acetaminophen administered to trap glutathione as an excretable adduct did not stimulate glutathione turnover, which reflects glutathione synthesis under steady-state conditions. No evidence for two pools of glutathione with different half-lives was found; previous reports of two glutathione pools may have failed to account for hepatic protein turnover with subsequent release of radiolabeled amino acids for glutathione synthesis. In male rats, the rate of glutathione turnover decreased from 0.52 per hr at 6 weeks of age to 0.12 per hr at 24 weeks of age. After acute depletion of glutathione by diethylmaleate, the rate of glutathione turnover promptly doubled in all age groups. Similar increases in the rate of glutathione synthesis and in the ability to stimulate glutathione production in response to acute depletion in children might explain their decreased susceptibility to acetaminophen hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7359370

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Liver and aging.

Authors:  K Kitani
Journal:  Gastroenterol Jpn       Date:  1992-04

Review 3.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

4.  Effect of excipients on acetaminophen metabolism and its implications for prevention of liver injury.

Authors:  Michael Ganetsky; Mark Böhlke; Luis Pereira; David Williams; Barbara LeDuc; Shiva Guatam; Steven D Salhanick
Journal:  J Clin Pharmacol       Date:  2013-02-22       Impact factor: 3.126

5.  Changes in organ nonprotein sulfhydryl and glutathione concentrations during acute and chronic administration of inorganic lead to chicks.

Authors:  C McGowan; W E Donaldson
Journal:  Biol Trace Elem Res       Date:  1986-07       Impact factor: 3.738

6.  A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.

Authors:  G Johanson; J G Filser
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration. Turnover studies.

Authors:  H Speisky; A MacDonald; G Giles; H Orrego; Y Israel
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

Review 8.  Paracetamol poisoning in children and hepatotoxicity.

Authors:  A Penna; N Buchanan
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

Review 9.  Nonsteroidal anti-inflammatory agents in neonates.

Authors:  John L Morris; David A Rosen; Kathleen R Rosen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Glutathione biosynthesis in the aging adult yellow-fever mosquito [Aedes aegypti (Louisville)].

Authors:  G A Hazelton; C A Lang
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.